HOME >> BIOLOGY >> NEWS
Perkin-Elmer, Dr. J. Craig Venter, And TIGR Announce Formation Of New Genomics Company

NORWALK, Conn. and ROCKVILLE, Md., May 9, 1998 -- The Perkin-Elmer Corporation (NYSE:PKN), Dr. J. Craig Venter, and The Institute for Genomic Research (TIGR) announced today that they have signed letters of intent relating to the formation by Perkin-Elmer and Dr. Venter of a new genomics company. Its strategy will be centered on a plan to substantially complete the sequencing of the human genome in three years.

The new company's goal is to become the definitive source of genomic and associated medical information that will be used by scientists to develop a better understanding of the biological processes in humans and deliver improved healthcare in the future. Using breakthrough DNA analysis technology being developed by Perkin-Elmer's Applied Biosystems Division, applied to sequencing strategies pioneered by Dr. Venter and others at TIGR, the company will operate a genomics sequencing facility with an expected capacity greater than that of the current combined world output.

Concurrently, the new company also intends to build the scientific expertise and informatics tools necessary to extract valuable biological knowledge from genomic data, including the discovery of new genes, development of polymorphism assay systems, and databases for the scientific community. Perkin-Elmer and Dr. Venter believe that this information has significant commercial value and that the new company can provide this information more rapidly and more accurately than is currently possible.

"The fundamentals of healthcare delivery and medical practice will be transformed by molecular medicine. We believe that the information developed by this new company will become the cornerstone of this new paradigm and accelerate development of new therapies, targeted diagnostics, and individualized medicine - providing therapies tailored specifically to a disease in an individual," noted Tony L. White, Perkin-Elmer's chairman, president and chief executive officer.

Mr. Wh
'"/>

Contact: Timothy Sipols
t.sipols@noonanrusso.com
212-696-4455 ext.272
Noonan/Russo Communications
9-May-1998


Page: 1 2 3 4

Related biology news :

1. Biotechnology Study Center Honors J. Craig Venter, Leonard Bell, and Steven Shak
2. Q & A with Dr. J Craig Venter, July 20th
3. Press availability: J. Craig Venter, Genome Project Chief, available for media inquiries
4. Announcement of the chicken genome sequence and genome variation maps
5. UV Rays, Fire And Flame Retardants To Be Reviewed For Possible Listing As Carcinogens, NTP Announces
6. American Heart Association Announces Top 10 Research Advances For 1998 -- Gene Therapy Among The List
7. Science Announces Top Ten Research Advances Of 1998
8. AAAS Announces The Winners Of Its Science Journalism Awards
9. Researchers Announce Breakthrough In Transgenic Animal Technology
10. Fred Hutchinson Cancer Research Center And Targeted Genetics Announces Issuance Of Braod Patent Covering Antigen-Specific T Cell Expansion
11. Discovery Of Possible New Weight Control Role For Leptin Announced By Yale University School Of Medicine Researchers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/4/2019)... ... January 03, 2019 , ... ... cell culture models into their drug discovery research workflows with biology ranging from ... in vivo relevancy of in vitro studies, they create several challenges that need ...
(Date:12/22/2018)... BOSTON (PRWEB) , ... December 21, 2018 , ... ... office sponsored and hosted the Boston Healthcare Drinks event featuring Helen Chen, ... Opportunities Arising from China.” , The discussion was moderated by patent attorney ...
(Date:12/18/2018)... ... December 18, 2018 , ... The nation’s leader ... client marketing. The technology has been effective at reducing patient acquisition costs by ... working with clients nationwide on patient acquisition marketing programs. Traditional marketing for stem ...
Breaking Biology News(10 mins):
(Date:12/19/2018)... ... 2018 , ... RURO, Inc., a leading provider of information ... The new release enhances the latest version of Limfinity®, RURO’s software framework, and ... , Validation protocols, and their execution, are critical for software systems scrutinized by ...
(Date:12/18/2018)... (PRWEB) , ... December 18, 2018 , ... ... business process optimization firm for the life sciences industry, unveiled a completely redesigned ... while creating a more user-friendly browsing experience for their valued clients and business ...
(Date:12/14/2018)... EDMONTON, Alberta (PRWEB) , ... December 14, 2018 ... ... the Eye Machine Canada Inc., have been given the green light to immediately ... Age-Related Macular Degeneration (AMD). , The medical devices bureau of Health Canada has ...
(Date:12/13/2018)... , ... December 12, 2018 , ... ... life science software solutions, announces the Limfinity® ML (Machine Learning) addition for its ... machine learning models within Limfinity® solutions. In the module, trained models make predictions ...
Breaking Biology Technology:
Cached News: